Emmaus Medical
  • CEO Letters
  • Overview
    • Mission
    • Leadership
      • Management Team
      • Board of Directors
    • Corporate Compliance
    • Corporate Governance
  • Products
    • Endari
  • Pipeline
    • Research Publications
    • Diverticulosis
    • Cell Sheet Engineering
  • News
    • Press Releases
    • Media Contacts
    • Media Kit
  • Investors
  • Career
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Management Team
    • Presentations
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Pre-merger Emmaus Life Science SEC Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Emmaus Life Sciences Announces Partnership with UpScript to Provide Telehealth Solutions to Sickle Cell Disease Patients

Nov 11, 2021 8:23am EST

Emmaus Life Sciences Enters into Agreement with Asembia to Provide Expanded Patient Support Services

Nov 04, 2021 8:23am EDT

Emmaus Life Sciences Submits Application for U.A.E. Marketing Authorization for Endari®

Oct 26, 2021 8:23am EDT

Emmaus Life Sciences Acquires Key Intellectual Property Rights to Novel IRAK4 Inhibitor From Kainos Medicine

Oct 12, 2021 8:23am EDT

Emmaus Life Sciences Reports Financial Results for the Six Months Ended June 30, 2021

Sep 02, 2021 8:45am EDT

Emmaus Life Sciences Announces Bahrain Temporary License of Endari®

Aug 17, 2021 8:45am EDT

Emmaus Life Sciences Provides SEC Reporting Update

Aug 10, 2021 8:45am EDT

Texas Adds Endari® to Latest Preferred Drug List

Aug 02, 2021 9:00am EDT

Emmaus Life Sciences Provides Interim Sales Information

Jul 22, 2021 9:00am EDT

Emmaus Life Sciences Announces Submission of Endari® Marketing Authorization Application in Kuwait

Jul 15, 2021 9:00am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...17
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Emmaus Medical, Inc. Registered ® Emmaus Medical, Inc, Torrance, CA. All rights reserved.

    • Privacy
    • Terms of Use
    • Contact